# Driver Ablation of Persistent Atrial Fibrillation With Severe Atrial Fibrosis.

> **NCT05085912** · NA · UNKNOWN · sponsor: **Shanghai Chest Hospital** · enrollment: 300 (estimated)

## Conditions studied

- Persistent Atrial Fibrillation

## Interventions

- **PROCEDURE:** Circumferential pulmonary vein isolation + linear ablation + bi-atrial mapping + driver ablation
- **PROCEDURE:** Circumferential pulmonary vein isolation + linear ablation + posterior wall box isolation
- **PROCEDURE:** Circumferential pulmonary vein isolation + linear ablation + vein of Marshall ethanol infusion

## Key facts

- **NCT ID:** NCT05085912
- **Lead sponsor:** Shanghai Chest Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-11-01
- **Primary completion:** 2024-10-31
- **Final completion:** 2024-10-31
- **Target enrollment:** 300 (ESTIMATED)
- **Last updated:** 2021-10-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05085912

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05085912, "Driver Ablation of Persistent Atrial Fibrillation With Severe Atrial Fibrosis.". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05085912. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*